A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)
Clinical trial NCT04628494 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04628494
- Sponsor
- Genmab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-13
- Primary completion
- 2025-10-13
- Enrollment
- 483
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.